共 164 条
[1]
McMurray JJ(2014)Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 993-1004
[2]
Packer M(2018)Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices Heart Rhythm 15 395-402
[3]
Desai AS(2003)Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline J Am Coll Cardiol 41 1510-8
[4]
Gong J(2017)Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes J Am Coll Cardiol 70 2476-86
[5]
Lefkowitz MP(2021)A year in heart failure: an update of recent findings ESC Heart Fail 8 4370-93
[6]
Rizkala AR(2019)Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction N Engl J Med 381 1609-20
[7]
de Diego C(2020)Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction Circulation 142 1236-45
[8]
González-Torres L(2018)Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure JACC Heart Fail 6 489-98
[9]
Núñez JM(2020)Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease ESC Heart Fail 7 1125-9
[10]
Centurión Inda R(2012)China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis BMC Nephrol 13 94-73